[go: up one dir, main page]

HK1220495A1 - 从材料和组合物中检测和富集病原体的方法 - Google Patents

从材料和组合物中检测和富集病原体的方法 Download PDF

Info

Publication number
HK1220495A1
HK1220495A1 HK16108498.2A HK16108498A HK1220495A1 HK 1220495 A1 HK1220495 A1 HK 1220495A1 HK 16108498 A HK16108498 A HK 16108498A HK 1220495 A1 HK1220495 A1 HK 1220495A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
enrichment
materials
pathogen detection
Prior art date
Application number
HK16108498.2A
Other languages
English (en)
Inventor
R. Henn Matthew
G. Aunins John
Berry David
N. Cook David
Original Assignee
Seres Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seres Therapeutics, Inc. filed Critical Seres Therapeutics, Inc.
Publication of HK1220495A1 publication Critical patent/HK1220495A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK16108498.2A 2013-03-14 2014-03-14 从材料和组合物中检测和富集病原体的方法 HK1220495A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361781854P 2013-03-14 2013-03-14
US201361781854P 2013-03-14
PCT/US2014/029539 WO2014153194A2 (en) 2013-03-14 2014-03-14 Methods for pathogen detection and enrichment from materials and compositions

Publications (1)

Publication Number Publication Date
HK1220495A1 true HK1220495A1 (zh) 2017-05-05

Family

ID=51581772

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108498.2A HK1220495A1 (zh) 2013-03-14 2014-03-14 从材料和组合物中检测和富集病原体的方法

Country Status (4)

Country Link
US (1) US20160040215A1 (zh)
EP (1) EP2971148A4 (zh)
HK (1) HK1220495A1 (zh)
WO (1) WO2014153194A2 (zh)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7687239B2 (en) 2003-07-12 2010-03-30 Accelrs Technology Corporation Sensitive and rapid determination of antimicrobial susceptibility
EP2531589B1 (en) 2010-02-01 2017-04-05 MikrobEX Bacteriotherapy for Clostridium difficile colitis
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
WO2012122314A2 (en) 2011-03-07 2012-09-13 Accelr8 Technology Corporation Rapid cell purification systems
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
DK3569690T3 (da) 2011-12-01 2024-11-11 Univ Tokyo Human-afledte bakterier som inducerer proliferation eller akkumulation af regulatoriske t-celler
WO2013112923A1 (en) 2012-01-26 2013-08-01 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
BR112014021388A2 (pt) 2012-02-29 2017-07-18 Ethicon Endo Surgery Inc composições de microbiota e métodos rela-cionados às mesmas
US10039777B2 (en) 2012-03-20 2018-08-07 Neuro-Lm Sas Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
CA3008794C (en) 2012-03-29 2021-03-16 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
SG11201408478QA (en) 2012-06-18 2015-02-27 Nugen Technologies Inc Compositions and methods for negative selection of non-desired nucleic acid sequences
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
PT3628161T (pt) 2012-11-23 2023-05-15 Seres Therapeutics Inc Composições bacterianas sinergísticas e métodos de produção e utilização das mesmas
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
JP6479685B2 (ja) 2013-02-04 2019-03-06 セレス セラピューティクス インコーポレイテッド 病原性細菌生育の抑制のための組成物および方法
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
CA3013541C (en) 2013-03-14 2021-01-19 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
US10076546B2 (en) * 2013-03-15 2018-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
JP2016517687A (ja) 2013-03-27 2016-06-20 サンプル テクノロジーズ，インコーポレイティド 組換えファージ及び細菌検出方法
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
EP3011062A4 (en) * 2013-06-19 2017-06-14 Sample6 Technologies Inc. Phage-based bacterial detection assay
JP6637885B2 (ja) 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
ES3017865T3 (en) 2013-11-25 2025-05-13 Nestle Sa Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
WO2016070151A1 (en) 2014-10-31 2016-05-06 Whole Biome. Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
ES3010296T3 (en) * 2014-11-25 2025-04-02 Memorial Sloan Kettering Cancer Center Intestinal microbiota and gvhd
HUE035569T2 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd Bacteroides thetaiotaomicron strain and its use in reducing inflammation
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
GB201505364D0 (en) * 2015-03-27 2015-05-13 Genetic Analysis As Method for determining gastrointestinal tract dysbiosis
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
AU2016243656A1 (en) 2015-03-30 2017-11-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
CA3247865A1 (en) * 2015-04-23 2025-10-31 Bd Kiestra B.V. An automated method for evaluating microbial growth using colony contrast
EP4545082A3 (en) 2015-05-06 2025-07-02 SNIPR Technologies Limited Altering microbial populations & modifying microbiota
US20160362680A1 (en) * 2015-05-15 2016-12-15 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
BR112017026586B1 (pt) 2015-06-09 2021-11-03 Rebiotix, Inc. Composições de terapia de restauração de microbiota (mrt) e métodos de fabricação
HUE045413T2 (hu) 2015-06-15 2019-12-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
ES2753779T3 (es) * 2015-06-15 2020-04-14 4D Pharma Res Ltd Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
AU2016318112B2 (en) * 2015-09-04 2021-11-04 Memorial Sloan-Kettering Cancer Center Methods and compositions for detecting risk of cancer relapse
EP4066846A1 (en) * 2015-11-03 2022-10-05 The Brigham & Women's Hospital, Inc. Therapeutic microbiota for the treatment and/or prevention of food allergy
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017100420A1 (en) * 2015-12-08 2017-06-15 Mayo Foundation For Medical Education And Research Biomarkers for predicting clostridium difficile infection treatment outcome
US20190062800A1 (en) * 2016-01-27 2019-02-28 Abdennour Abbas Methods of attaching probes to microorganisms and methods of use thereof
JP2019504647A (ja) * 2016-02-11 2019-02-21 ニューバイヨタ・リミテッド・ライアビリティ・カンパニーＮｕｂｉｙｏｔａ， ＬＬＣ 糞便由来の細菌集団を含む組成物を特徴付けるためのシステムおよび方法
SG11201807195VA (en) 2016-03-04 2018-09-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
US10894990B2 (en) * 2016-05-17 2021-01-19 Shoreline Biome, Llc High throughput method for identification and sequencing of unknown microbial and eukaryotic genomes from complex mixtures
US11707493B2 (en) 2016-05-23 2023-07-25 California Institute Of Technology Regulate gut microbiota to treat neurodegenerative disorders
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
PT3468573T (pt) 2016-06-14 2023-10-16 Vedanta Biosciences Inc Tratamento de uma infeção por clostridium difficile
US9999641B2 (en) 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
SG11201908571UA (en) * 2017-03-17 2019-10-30 Second Genome Inc Leveraging sequence-based fecal microbial community survey data to identify a composite biomarker for colorectal cancer
WO2018213204A1 (en) 2017-05-15 2018-11-22 Axial Biotherapeutics, Inc. Inhibitors of microbially induced amyloid
WO2018213262A1 (en) 2017-05-19 2018-11-22 Memorial Sloan-Kettering Cancer Center Methods and compositions for reducing listeria monocytogenes infection or colonization
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
ES2855701T3 (es) 2017-06-14 2021-09-24 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
CN107164438B (zh) * 2017-07-13 2021-03-23 陕西科技大学 一种提高短短芽孢杆菌细菌素生产水平的发酵方法
US20210317508A1 (en) * 2017-08-01 2021-10-14 Axial Therapeutics, Inc. Methods and apparatus for determining risk of autism spectrum disorder
JP2020530840A (ja) 2017-08-14 2020-10-29 セレス セラピューティクス インコーポレイテッド 胆汁うっ滞性疾患を治療するための組成物及び方法
EP3675882A4 (en) 2017-08-30 2021-07-28 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
RU2020117775A (ru) * 2017-10-30 2021-12-01 Серес Терапеутикс, Инк. Композиции и способы для лечения устойчивости к антибиотикам
US11708616B2 (en) * 2017-11-16 2023-07-25 American Molecular Laboratories Inc. Methods for detection of antibiotic resistant H. pylori
CA3087695C (en) * 2018-01-05 2023-08-22 Nubiyota Llc Compositions comprising co-selected microbiota and methods for use thereof
DK3746225T3 (da) * 2018-01-29 2025-01-13 Gen Probe Inc Analytiske systemer og fremgangsmåder
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
EP3823651A4 (en) 2018-07-19 2022-04-27 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION
JP7558170B2 (ja) 2018-08-17 2024-09-30 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 腸内毒素症を減少させ、微生物叢を復元する方法
WO2020069282A1 (en) * 2018-09-27 2020-04-02 Research Development Foundation Methods and probiotic compositions for the treatment of bone disorders
CN111019873B (zh) * 2018-10-09 2022-08-19 安徽吐露港生物科技有限公司 在食气梭菌基因组上快速整合大片段dna的方法
US20250268951A1 (en) * 2018-12-27 2025-08-28 The Chinese University Of Hong Kong Therapeutic and prophylactic use of microorganisms
CA3132912A1 (en) * 2019-03-13 2020-09-17 Goodgut S.L. Improved method for the screening, diagnosis and/or monitoring of colorectal advanced neoplasia, advanced adenoma and/or colorectal cancer
CA3141582A1 (en) * 2019-05-23 2020-11-26 American Molecular Laboratories, Inc. Methods for detection of rare dna sequences in fecal samples
CA3147629A1 (en) * 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
CN110699468B (zh) * 2019-10-29 2023-05-02 圣湘生物科技股份有限公司 检测人肠道细菌的组合物、试剂盒及方法
US20230000921A1 (en) * 2019-11-08 2023-01-05 Virginia Commonwealth University Changing gut microbiota to reduce alcohol craving
CN113122646A (zh) * 2020-01-15 2021-07-16 中国科学院昆明动物研究所 炎性肠病特异性肠道微生物检测靶标及其应用
TW202203950A (zh) * 2020-03-30 2022-02-01 香港商香港微生物菌群創新中心有限公司 微生物在調節體重和膽固醇水準中的用途
WO2022108982A1 (en) * 2020-11-17 2022-05-27 Yale University Targeting host-bacteria interactions for the treatment of microbiota-mediated diseases
AU2021386691A1 (en) 2020-11-26 2023-07-06 4D Pharma Leon, S.L.U. Process
CN113493847B (zh) * 2021-06-24 2022-04-19 北京工业大学 基于PMA高通量测序和PICRUSt的抗生素抗性基因及潜在宿主细菌的鉴定方法
FR3125124B1 (fr) * 2021-07-07 2025-02-28 Commissariat Energie Atomique Procédé d'analyse d'un échantillon pour y détecter la présence d'une forme active d'une espèce biologique
WO2023177875A1 (en) * 2022-03-17 2023-09-21 Evelo Biosciences, Inc. Methods and compositions for anaerobic contaminant testing
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
JP7279983B1 (ja) 2022-09-21 2023-05-23 学校法人近畿大学 腸内細菌培養組培地、及び腸内細菌培養方法。
EP4386091A1 (en) * 2022-12-14 2024-06-19 The BioArte Limited A method for taxonomic classification up to species level of bacteria
CN117965764B (zh) * 2024-01-16 2024-08-30 南方医科大学珠江医院 一种荧光原位杂交的组合物、荧光原位杂交探针试剂盒及其应用
WO2025168557A1 (en) * 2024-02-08 2025-08-14 Unilever Ip Holdings B.V. Detection method for microbial contaminants in detergents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO430496A0 (en) * 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
US20050048515A1 (en) * 2003-08-29 2005-03-03 Garner Bryan E. Methods for detecting and quantifying specific probiotic microorganisms in animal feed
PL1812585T3 (pl) * 2004-11-01 2015-03-31 Erber Ag Bakteriofagi jako czynniki selekcyjne
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments

Also Published As

Publication number Publication date
EP2971148A4 (en) 2016-08-17
EP2971148A2 (en) 2016-01-20
WO2014153194A2 (en) 2014-09-25
WO2014153194A3 (en) 2014-12-11
US20160040215A1 (en) 2016-02-11
WO2014153194A4 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
HK1220495A1 (zh) 从材料和组合物中检测和富集病原体的方法
HK1220326A1 (zh) 基於网络微生物组成和方法
EP3083979A4 (en) Cell detection, capture and isolation methods and apparatus
WO2016094839A3 (en) Compositions and methods for performing methylation detection assays
ZA201703635B (en) Use of l. reuteri for recovery of microbiota dysbiosis in early life
EP2921432A4 (en) MACHINE FOR INSPECTING AND DETECTING DEFECTS IN FRUIT PRODUCTS AND ASSOCIATED METHODS
WO2014160441A8 (en) Neuroactive steroids, compositions, and uses thereof
EP3221813A4 (en) Methods relating to the detection of recurrent and non-specific double strand breaks in the genome
ZA201503554B (en) Compositions for balancing gut microbiota and the preparation and the uses thereof
MX360384B (es) Metodo rapido para la deteccion de patogenos.
SG10201705024PA (en) Methods and compositions for separating or enriching cells
EP3024947A4 (en) Methods and compositions for detecting bacterial contamination
IL238130A0 (en) The pr13.5 promoter for stable t cell and antibody responses
PL3218113T3 (pl) Wirówka i sposób rejestracji niewyważeń w wirówce
IL244391A0 (en) A method for evaluating the effects of a preparation containing microorganisms on intestinal microbiota
EP3039416A4 (en) Method and apparatus for isolation, capture and molecular analysis of target particles
PH12013502363A1 (en) Avirulent modified salmonella gallinarum strains and pharmaceutical composition using the same
EP2841558A4 (en) ONCOLYTIC CLOSTRIDIUM GHONII STRAINS AND METHOD FOR THE PREPARATION AND USE THEREOF
EP3093661A4 (en) Artificial cell membrane comprising supported lipid bilayer in which metal particle probe having controlled mobility is coupled, and method for analyzing molecular interaction by using same
WO2014151879A3 (en) Method of capturing bacteria on polylysine-coated microspheres
EP3194960A4 (en) Biosensors for monitoring biomolecule localization and trafficking in cells
EP3085771A4 (en) Method for detecting bacteria of the genus streptococcus in milk
EP3108045A4 (en) Compositions and methods for detecting microorganisms
EP3191607A4 (en) Compositions and methods for the detection and analysis of mycobacterium tuberculosis
EP3147371A4 (en) Novel method for detecting detection object in sample, and detection kit using same